Alon Ben-Noon is the Co-founder and CEO, of NeuroSense Therapeutics, a drug development company focusing on the treatment of ALS and other neurodegenerative diseases.
*This interview was conducted in January of 2022*
Since the interview, NeuroSense successfully concluded additional biomarker...
Published 08/16/22
In this episode, we're speaking with Cecile Blilious, who is the head of impact and sustainability at Pitango Venture Capital.
Interview questions
00:56 Tell us about your professional journey and what brought you to where you are today?
03:03 How would you define impact investments? And what...
Published 10/31/21